Literature DB >> 34098412

On the efficacy of the unified protocol for transdiagnostic treatment of emotional disorders: A systematic review and meta-analysis.

Leonardo Carlucci1, Aristide Saggino2, Michela Balsamo2.   

Abstract

In recent years a large array of treatment protocols conceptualized as transdiagnostic have been developed with clinical and practical advantages compared to traditional single-disorder protocols. Within this panorama, the Transdiagnostic Unified Protocol (UP) of Emotional Disorders was developed aimed at treating the negative affective processes underlying several diagnostic categories, and accounting for the covariance of different emotional disorders. The UP has been found to efficiently target the roots of these disorders leading to a reduction in symptoms of co-occurring disorders. However, several questions have marginally addressed in the previous studies, and some UP features still remain unexplored. The present meta-analysis aims at evaluating whether the UP results to significant changes in anxiety and depression symptoms severity in children, adolescents, and adults. 19 RCTs and 13 uncontrolled pre-post trials comprising 2183 patients/clients met inclusion criteria for meta-analysis. Large to moderate combined overall effect size for both depression plus anxiety were detected in the uncontrolled pre-post studies (g = 0.756) and in RTCs studies (g = 0.452), respectively. Large effect size at pre-treatment to 3-6-month follow-up was observed for combined depression plus anxiety (g = 1.113). Subgroup analysis suggested that UP treatment does not differ across the anxiety and depression self-report measures. Moreover, UP intervention outperformed both passive and active control conditions to treat negative affective syndromes. Meta-regression confirmed the moderate effects of therapist level of experience, the sample characteristics, and the UP-protocol adaptations. The findings indicate that the manualized UP treatment has potential to contribute to improving mental health outcomes, particularly of anxiety and depression.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety; Depression; Meta-analysis; Transdiagnostic; Treatment outcome; Unified protocol

Mesh:

Year:  2021        PMID: 34098412     DOI: 10.1016/j.cpr.2021.101999

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  12 in total

1.  Patterns of childhood maltreatment predict emotion processing and regulation in emerging adulthood.

Authors:  Jennifer M Warmingham; Erinn B Duprey; Elizabeth D Handley; Fred A Rogosch; Dante Cicchetti
Journal:  Dev Psychopathol       Date:  2022-03-15

2.  Assessment of Acceptability and Initial Effectiveness of a Unified Protocol Prevention Program to Train Emotional Regulation Skills in Female Nursing Professionals during the COVID-19 Pandemic.

Authors:  Vanesa Ferreres-Galán; María Vicenta Navarro-Haro; Óscar Peris-Baquero; Silvia Guillén-Marín; Jordi de Luna-Hermoso; Jorge Osma
Journal:  Int J Environ Res Public Health       Date:  2022-05-07       Impact factor: 4.614

3.  Effectiveness and mechanism of a 4-week online self-help mindfulness intervention among individuals with emotional distress during COVID-19 in China.

Authors:  Ruilin Ju; Wingsze Chiu; Yinyin Zang; Stefan G Hofmann; Xinghua Liu
Journal:  BMC Psychol       Date:  2022-06-13

4.  Implementation, efficacy and cost effectiveness of the unified protocol in a blended format for the transdiagnostic treatment of emotional disorders: a study protocol for a multicentre, randomised, superiority controlled trial in the Spanish National Health System.

Authors:  J Osma; Laura Martínez-García; Óscar Peris-Baquero; María Vicenta Navarro-Haro; Alberto González-Pérez; Carlos Suso-Ribera
Journal:  BMJ Open       Date:  2021-12-31       Impact factor: 2.692

5.  Cost-effectiveness and cost-utility evaluation of individual vs. group transdiagnostic psychological treatment for emotional disorders in primary care (PsicAP-Costs): a multicentre randomized controlled trial protocol.

Authors:  Ángel Aguilera-Martín; Mario Gálvez-Lara; Fátima Cuadrado; Eliana Moreno; Francisco García-Torres; José F Venceslá; Jorge Corpas; Francisco J Jurado-González; Roger Muñoz-Navarro; César González-Blanch; Paloma Ruiz-Rodríguez; Sara Barrio-Martínez; Maider Prieto-Vila; María Carpallo-González; Antonio Cano-Vindel; Juan A Moriana
Journal:  BMC Psychiatry       Date:  2022-02-09       Impact factor: 3.630

Review 6.  Toward a Unified Framework for Positive Psychology Interventions: Evidence-Based Processes of Change in Coaching, Prevention, and Training.

Authors:  Joseph Ciarrochi; Steven C Hayes; Lindsay G Oades; Stefan G Hofmann
Journal:  Front Psychol       Date:  2022-02-10

7.  Prevalence and comorbidity of psychiatric disorders among treatment-seeking elite athletes and high-performance coaches.

Authors:  Cecilia Åkesdotter; Göran Kenttä; Sandra Eloranta; Anders Håkansson; Johan Franck
Journal:  BMJ Open Sport Exerc Med       Date:  2022-03-29

8.  The efficacy of transdiagnostic cognitive behavioural therapy on reducing negative affect, anxiety sensitivity and improving perceived control in children with emotional disorders - a randomized controlled trial.

Authors:  Elham Qanbari Alaee; Omid Saed; Sahel Khakpoor; Reza Ahmadi; Mahsa Ali Mohammadi; Majid Yoosefi Afrashteh; Zekrolah Morovati
Journal:  Res Psychother       Date:  2022-05-09

9.  Effectiveness of the internet-based Unified Protocol transdiagnostic intervention for the treatment of depression, anxiety and related disorders in a primary care setting: a randomized controlled trial.

Authors:  Ladislav Timulak; Derek Richards; Louise Bhandal-Griffin; Patrick Healy; Juliana Azevedo; Graham Connon; Elaine Martin; Aoife Kearney; Conor O'Kelly; Angel Enrique; Nora Eilert; Sorcha O'Brien; Siobhan Harty; Alberto González-Robles; Elizabeth H Eustis; David H Barlow; Todd J Farchione
Journal:  Trials       Date:  2022-08-31       Impact factor: 2.728

10.  Application of unified protocol as a transdiagnostic treatment for emotional disorders during COVID-19: An internet-delivered randomized controlled trial.

Authors:  Kou Yan; Mohammad Hassan Yusufi; Nabi Nazari
Journal:  World J Clin Cases       Date:  2022-08-26       Impact factor: 1.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.